The Microbiome Times

With over 100 trillion bacteria and other microbes estimated to inhibit the human body alone, we are seeing new knowledge and applications of microbiomes develop at an alarming rate, bringing with it new licensing agreements, large investments, IPOs, strategic partnerships and acquisitions across the Pharma and Human Health, Animal Health and Agriculture industries. Microbiome TimesTM aims to assist science entrepreneurs to acquire insights that will expand the envelope of applied microbiome knowledge and offers a one-stop-shop to stay up to date with this fast paced industry.